Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $90.00. The ...
Dexcom’s G7 Hospital CGM Poised for Market Breakthrough with NTAP and FDA Approvals
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price ...